Drug Name |
Sotalol hydrochloride |
Drug ID |
BADD_D02061 |
Description |
Sotalol is a methanesulfonanilide developed in 1960.[A178579] It was the first of the class III anti arrhythmic drugs.[A178579] Sotalol was first approved as an oral tablet on 30 October 1992.[L6334] A racemic mixture of sotalol is currently formulated as a tablet, oral solution, and intravenous injection indicated for life threatening ventricular arrhythmias and maintaining normal sinus rhythm in atrial fibrillation or flutter.[Label,L6373,L6376] |
Indications and Usage |
For the maintenance of normal sinus rhythm [delay in time to recurrence of atrial fibrillation/atrial flutter (AFIB/AFL)] in patients with symptomatic AFIB/AFL who are currently in sinus rhythm. Also for the treatment of documented life-threatening ventricular arrhythmias. |
Marketing Status |
Prescription; Discontinued |
ATC Code |
C07AA07 |
DrugBank ID |
DB00489
|
KEGG ID |
D01026
|
MeSH ID |
D013015
|
PubChem ID |
66245
|
TTD Drug ID |
D04VMT
|
NDC Product Code |
60505-0224; 63629-2421; 60429-751; 0904-7143; 71610-474; 60429-748; 63629-2422; 69584-841; 0245-0013; 60505-0081; 10135-717; 60505-0082; 63629-2423; 71610-294; 58032-0803; 42806-122; 60429-750; 76385-116; 50268-724; 72789-135; 55154-8179; 10135-715; 70515-106; 42806-121; 71335-0860; 71335-1125; 76385-114; 10135-716; 63187-426; 50268-725; 10135-661; 0093-1062; 72789-138; 69584-844; 69724-112; 71610-385; 70515-119; 43353-616; 71205-046; 70515-115; 10920-572; 60505-0159; 52932-0715; 0093-1060; 0245-0012; 50090-1299; 71335-0260; 0093-1061; 71335-1189; 70515-116; 60505-0080; 42806-123; 60505-0223; 72789-137; 10135-662; 0245-0014; 68084-654; 60505-0222; 70515-109; 76385-115; 70515-105; 60429-749; 69584-843; 10135-663; 72789-136; 71335-1917; 70518-3341; 12828-0071; 0093-1063; 69584-842; 24338-530; 71610-074; 0245-0015; 63187-804 |
Synonyms |
Sotalol | Sotalol Hydrochloride | Sotalol Monohydrochloride | MJ-1999 | MJ 1999 | MJ1999 | Darob |